COVERAGE ENGINE · PRODUCT + DIAGNOSIS + INSURANCE

How do I get Yartemlea
through my insurance?

Yartemlea · narsoplimab-wuug · MASP-2 inhibitor · IV infusion

Coverage first → benefit/formulation → assistance
Yartemlea / narsoplimab-wuug coverage engine.

New provider-administered therapy for transplant-associated thrombotic microangiopathy with transplant-setting, medical-benefit and new-to-market access considerations.

No account, member ID, name, date of birth or email is needed. Your selections stay in this page session.

1
WHY IS THIS MEDICINE BEING GIVEN?

Choose the diagnosis / reason.

Coverage rules can change by diagnosis and sometimes by formulation.

AFTER COVERAGE

Then solve the patient’s out-of-pocket cost.

Financial assistance only helps after the correct product/formulation and benefit path are known.

YARTEMLEAssist — patient access support →

Important

MedicineCostHelp is an educational navigation tool, not an insurer and not a coverage determination. Medical policies, billing codes, product preferences and benefit placement can change. Sources in this batch were checked 2026-08-21.

Search another expensive medicine →